Resource Center

Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
Quotient Sciences Logo
GLP1, Oral Peptides, Dr. Andy Lewis

On-Demand: A Deep Dive Into the CMC, Technology and Financial Aspects of Successful Development of an Orally Delivered GLP-1

31 October 2024 Learn more

41 - 50 of 214 results

Scientific Poster, First-in-Human
BPS 2022 Poster: A Phase 1 Randomized PK Study of Amilo-5MER
22 September 2022
Download Now
Scientific Poster, Clinical Pharmacology, First-in-Human
A Phase 1, Randomized, Double-Blind, Placebo Controlled, First-in-Human Study to Assess Safety, Tolerability & Pharmacokinetics (PK) of Amilo-5MER in Healthy Volunteers
13 September 2022
Download Now
On-Demand Webinar, Modified Release, Commercial Manufacturing, Formulation Development
Non-Clinical vs Clinical: Risks & Considerations When Developing Modified Release Dosage Forms
1 September 2022
Watch Now
Scientific Poster, Translational Pharmaceutics, Clinical Pharmacology, Formulation Development
Assessment of the Contribution of CYP2D6 to the Elimination of Idalopirdine as well as the Absolute Bioavailability Following Multiple Oral Dosing
26 August 2022
Download Now
Peer Reviewed Publication, Clinical Pharmacology
CC-99677: A Novel, Oral, Selective Covalent MK2 Inhibitor, Sustainably Reduces Pro-inflammatory Cytokine Production
23 August 2022
Download Now
Peer Reviewed Publication, Clinical Pharmacology
CC-99677, A Novel, Oral, Selective Covalent MK2 Inhibitor, Sustainably Reduces Pro-inflammatory Cytokine Production
23 August 2022
Download Now
Peer Reviewed Publication, Human ADME
ADME of opicapone in human healthy volunteers
16 June 2022
Download Now
On-Demand Webinar, Translational Pharmaceutics
Getting it Right Early: The Importance of Biopharmaceutics in Early Drug Development
1 June 2022
Watch Now
Scientific Poster, Translational Pharmaceutics, Clinical Trial Manufacturing, First-in-Human
Why Archiving is a Crucial Part of Any Clinical Trial
17 May 2022
Download Now
Peer Reviewed Publication, Translational Pharmaceutics, Clinical Pharmacology, First-in-Human
Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial
3 May 2022
Download Now
Get in touch
Humanity can't afford to wait, so neither can we.
Let's talk